#1
Posted: Thu Feb 05, 2026 7:05 am
A team of researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved for treating irregular heartbeat to selectively target specific functions of enzymes in lymphoma, effectively killing cancer cells and reducing tumor growth with little to no toxicity. Recent findings published in Pharmacological Research set the groundwork for how this strategy could help transform the future of precision medicine in cancer.
Source: https://medicalxpress.com/news/2026-02- ... phoma.html
Source: https://medicalxpress.com/news/2026-02- ... phoma.html